OrbiMed Raises $551M For Third Asia-Focused Healthcare Fund

Sep 5 2017 | 9:42pm ET

Healthcare-focused investment manager OrbiMed Advisors has raised $551 million in capital commitments for its third Asia-focused private equity fund.

The new fund, named OrbiMed Asia Partners III, will invest broadly across the Asian healthcare industry and concentrate on growth stage product- and services-oriented companies in China and India, the company said in a statement. It will target investments from $10 million to $75 million per company across 15 to 20 opportunities, although where appropriate, the fund may co-invest with OrbiMed’s global team on substantially larger investments. 

OrbiMed’s Shanghai office was opened in 2007, while the company’s Mumbai office was opened in 2008. The firm raised $325 million in September 2014 for its second Asian healthcare fund.

OrbiMed is a healthcare investment firm with more than $14 billion in assets under management. The company invests globally across the healthcare industry, from start-ups to large multinational corporations, utilizing a range of private equity funds, public equity funds, and royalty/credit funds. 


In Depth

Q&A: Star Mountain's Brett Hickey On Investing In 'The Growth Engine Of America'

Sep 22 2017 | 5:06pm ET

Lower middle-market companies form the economic fabric of the nation, but they can...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Don’t Overlook These 6 Hybrid Cloud Concerns

Sep 14 2017 | 6:27pm ET

Cloud-based technology solutions have made tremendous inroads into the alternative...

 

From the current issue of

With NFL season on the horizon, it’s time to take a look at our Fantasy Football value picks. Last year, we nailed it on Drew Brees, Jordan Howard, Frank Gore and Dwayne Allen. We missed pretty badly on Duke Johnson, Demaryius Thomas, Mohammed Sanu and Eli Manning.